EURONEXT 100

EURONEXT 100 handeln
1.909,48 PKT +10,45 PKT +0,55 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN FR0003502079


Analysen zu EURONEXT 100-Werten

Datum Rating Analyst
17.04.20 LVMH Moet Hennessy Louis Vuitton Hold Jefferies & Company Inc.
17.04.20 LVMH Moet Hennessy Louis Vuitton Outperform RBC Capital Markets
17.04.20 Philips Neutral JP Morgan Chase & Co.
16.04.20 Airbus Outperform Credit Suisse Group
16.04.20 LVMH Moet Hennessy Louis Vuitton Outperform Bernstein Research
16.04.20 AIR France-KLM Reduce Kepler Cheuvreux
16.04.20 VINCI buy UBS AG
16.04.20 VINCI overweight JP Morgan Chase & Co.
16.04.20 Société Générale (Societe Generale) Neutral Oddo BHF
16.04.20 ING Group Neutral Oddo BHF
16.04.20 BNP Paribas buy Oddo BHF
16.04.20 ASML NV buy Oddo BHF
16.04.20 ASML NV buy UBS AG
16.04.20 Renault Neutral UBS AG
16.04.20 Société Générale (Societe Generale) Neutral UBS AG
16.04.20 BNP Paribas buy UBS AG
16.04.20 Airbus buy Kepler Cheuvreux
16.04.20 JCDecaux Neutral UBS AG
16.04.20 Vivendi buy UBS AG
16.04.20 STMicroelectronics overweight Barclays Capital
16.04.20 Holcim overweight JP Morgan Chase & Co.
16.04.20 Saint-Gobain Neutral JP Morgan Chase & Co.
16.04.20 Schneider Electric buy HSBC
16.04.20 LOréal Hold HSBC
16.04.20 Danone buy HSBC
16.04.20 Vivendi Outperform Credit Suisse Group
16.04.20 ASML NV Outperform Credit Suisse Group
16.04.20 ASML NV buy Goldman Sachs Group Inc.
16.04.20 AIR France-KLM Sell Deutsche Bank AG
15.04.20 Orange buy Deutsche Bank AG
15.04.20 TotalEnergies Outperform RBC Capital Markets
15.04.20 ASML NV Outperform Bernstein Research
15.04.20 ASML NV Outperform Credit Suisse Group
15.04.20 Orange buy Goldman Sachs Group Inc.
15.04.20 TotalEnergies buy Goldman Sachs Group Inc.
15.04.20 AXA Neutral UBS AG
15.04.20 ASML NV Hold Kepler Cheuvreux
15.04.20 AB InBev SA-NV (Anheuser-Busch InBev) Outperform Bernstein Research
15.04.20 ASML NV buy UBS AG
15.04.20 Sanofi Outperform Bernstein Research